Savara Inc
(NAS:SVRA)
$
4.96
0.01 (0.2%)
Market Cap: 815.60 Mil
Enterprise Value: 697.48 Mil
PE Ratio: 0
PB Ratio: 5.64
GF Score: 42/100 Savara Inc (SVRA) Transcripts
- Savara Inc at Guggenheim Healthcare Talks Biotechnology Conference TranscriptFeb 07, 2024
- Savara Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Savara Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Savara Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Q2 2020 Savara Inc Earnings Call TranscriptAug 06, 2020$2.04 (-3.77%)Earnings
- Savara Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Q1 2020 Savara Inc Earnings Call TranscriptMay 07, 2020$2.55 (+5.81%)Earnings
- Savara Inc. - Special Call TranscriptApr 03, 2020
- Q4 2019 Savara Inc Earnings Call TranscriptMar 12, 2020$2.55 (+8.05%)Earnings
- Q3 2019 Savara Inc Earnings Call TranscriptNov 07, 2019$0.91 (-1.09%)Earnings
- Q2 2019 Savara Inc Earnings Call TranscriptAug 08, 2019$2.51 (+2.03%)Earnings
- Savara Inc Announces Results of IMPALA, a Phase 3 Study of Molgradex for the Treatment of Autoimmune Alveolar Pulmonary Proteinosis (aPAP) TranscriptJun 12, 2019
- Q1 2019 Savara Inc Earnings Call TranscriptMay 09, 2019$10.72 (-2.46%)Earnings
- Q4 2018 Savara Inc Earnings Call TranscriptMar 13, 2019$8.6 (+1.30%)Earnings
- 1